Dengue vaccine unit dose and administration thereof

MYPI2025007474A0Undetermined Publication Date: 2020-03-05TAKEDA VACCINES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025007474
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-03-07
Filing Date
2019-09-05
Publication Date
2020-03-05
Patent Text Reader

Abstract

The invention relates to a unit dose of a dengue vaccine composition and methods and uses for preventing dengue disease and methods for stimulating an immune response to all four dengue virus serotypes in a subject or subject population. The unit dose of a dengue vaccine composition includes constructs of each dengue serotype, such as TDV-1, TDV-2, TDV-3 and TDV-4, at various concentrations in order to improve protection from dengue infection. Fig. 1
Need to check novelty before this filing date? Find Prior Art